Landos Biopharma, Inc. Debt to Equity Ratio 2021-2024 | LABP
Current and historical debt to equity ratio values for Landos Biopharma, Inc. (LABP) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Landos Biopharma, Inc. debt/equity for the three months ending March 31, 2024 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-03-31 |
$0.01B |
$0.02B |
0.29 |
2023-12-31 |
$0.01B |
$0.03B |
0.20 |
2023-09-30 |
$0.01B |
$0.04B |
0.15 |
2023-06-30 |
$0.00B |
$0.04B |
0.07 |
2023-03-31 |
$0.00B |
$0.05B |
0.09 |
2022-12-31 |
$0.01B |
$0.04B |
0.16 |
2022-09-30 |
$0.01B |
$0.04B |
0.12 |
2022-06-30 |
$0.01B |
$0.05B |
0.13 |
2022-03-31 |
$0.02B |
$0.06B |
0.25 |
2021-12-31 |
$0.02B |
$0.08B |
0.22 |
2021-09-30 |
$0.01B |
$0.09B |
0.12 |
2021-06-30 |
$0.01B |
$0.11B |
0.12 |
2021-03-31 |
$0.01B |
$0.10B |
0.09 |
2020-12-31 |
$0.08B |
$-0.05B |
-1.56 |
2020-09-30 |
$0.00B |
|
0.00 |
2020-06-30 |
$0.00B |
|
0.00 |
2020-03-31 |
$0.00B |
|
0.00 |